(2026). Preclinical evaluation of [F]fluoroethylresorufin as PET tracer for cerebral amyloid angiopathy. EJNMMI Research.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Preclinical Evaluation of [F]fluoroethylresorufin as PET Tracer for Cerebral Amyloid Angiopathy."
EJNMMI Research 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Preclinical Evaluation of [F]fluoroethylresorufin as PET Tracer for Cerebral Amyloid Angiopathy."
EJNMMI Research, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.